LSE · AOTI.L
AOTI, Inc.
£1.33+£0.01 (+0.76%)
AOTI, Inc.’s quoted price sits in the upper half of its reported 52-week range, 11.67% below the high.
Loading market information…
LSE · KOO.L · GBp
Stock price, earnings
Quote as of Oct 29, 2026, 04:22 PM UTC. Cached market data; not a live quote.
One-year closing-price history · GBp. Historical prices are not a forecast.
Kooth plc’s quoted price sits in the upper half of its reported 52-week range, 6.65% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Kooth plc’s next earnings report is currently expected on Mar 30, 2027, with estimated earnings per share of £0.03. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow Kooth plc’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Kooth plc, together with its subsidiaries, provides digital mental health services to children, young people, and adults in the United Kingdom. It operates online platforms that offers various therapeutic support and interventions, including anonymous and personalised mental health support; and a community with a library of peer and professional created content, as well as provides online counselling, coaching, and support services under the Kooth, Qwell, and Soluna names. The company was founded in 2001 and is headquartered in London, the United Kingdom.
Latest available per-share figures in GBP. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 03:42 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
| Q4 2022 | Dec 31, 2022 | -£0.01 | £11.10M |
|---|
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
£1.33+£0.01 (+0.76%)
AOTI, Inc.’s quoted price sits in the upper half of its reported 52-week range, 11.67% below the high.
£0.96£0.00 (0.0%)
ECO Animal Health Group plc’s quoted price sits in the lower half of its reported 52-week range, 18.31% below the high.
£0.10+£0.00 (+2.63%)
Ondine Biomedical Inc.’s quoted price sits in the upper half of its reported 52-week range, 37.1% below the high.
£0.11+£0.00 (+1.11%)
Creo Medical Limited’s quoted price sits in the lower half of its reported 52-week range, 38.51% below the high.
£6.80+£0.07 (+1.04%)
Hemogenyx Pharmaceuticals Plc’s quoted price sits in the lower half of its reported 52-week range, 44.26% below the high.
£0.06+£0.00 (+8.11%)
hVIVO plc’s quoted price sits in the lower half of its reported 52-week range, 45.45% below the high.
£0.04+£0.00 (+6.12%)
ImmuPharma PLC’s quoted price sits in the lower half of its reported 52-week range, 67.09% below the high.
£0.05-£0.00 (-2.68%)
Renalytix Plc’s quoted price sits in the upper half of its reported 52-week range, 35.12% below the high.
